EA
TMO icon

Euclid Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Euclid Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-77,509
Closed -$11.5M – 415
2016
Q2 		$11.5M Sell
77,509
-11,150
-13% -$1.65M 0.5% 56
2016
Q1 		$12.6M Sell
88,659
-32,298
-27% -$4.33M 0.48% 56
2015
Q4 		$17.2M Buy
+120,957
New +$16.1M 0.52% 56
2015
Q3 		– Sell
-222,845
Closed -$28.9M – 423
2015
Q2 		$28.9M Buy
222,845
+78,645
+55% +$10.3M 0.57% 43
2015
Q1 		$19.4M Buy
+144,200
New +$18.6M 0.36% 65
2014
Q4 		– Sell
-203,120
Closed -$24.7M – 492
2014
Q3 		$24.7M Buy
203,120
+12,910
+7% +$1.57M 0.18% 122
2014
Q2 		$22.4M Sell
190,210
-26,019
-12% -$3.06M 0.16% 149
2014
Q1 		$26M Buy
216,229
+71,770
+50% +$8.53M 0.2% 112
2013
Q4 		$16.1M Sell
144,459
-7,070
-5% -$703K 0.13% 166
2013
Q3 		$14M Buy
151,529
+31,669
+26% +$2.86M 0.14% 160
2013
Q2 		$10.1M Buy
+119,860
New +$9.98M 0.13% 190

Other funds holding TMO

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Euclid Advisors's TMO Position: Q3 2016 in Review

Euclid Advisors sold out of Thermo Fisher Scientific (TMO) in Q3 2016, closing a stake of 77,509 shares — an estimated $11.5M sold.

Euclid Advisors first reported a position in TMO in Q2 2013 and held it in 11 quarters. The position peaked at $28.9M in Q2 2015. 1,045 funds tracked by Wall St. Rank hold TMO as of Q3 2016.

  • Euclid Advisors reported no remaining Thermo Fisher Scientific position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 77,509 Thermo Fisher Scientific shares in Q3 2016, an estimated $11.5M.
  • Euclid Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 11 quarters.
  • Euclid Advisors's Thermo Fisher Scientific position peaked at $28.9M in Q2 2015.
  • 1,045 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.